Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 23;64(7):e00489-20.
doi: 10.1128/AAC.00489-20. Print 2020 Jun 23.

Pathogenicity Genomic Island-Associated CrpP-Like Fluoroquinolone-Modifying Enzymes among Pseudomonas aeruginosa Clinical Isolates in Europe

Affiliations

Pathogenicity Genomic Island-Associated CrpP-Like Fluoroquinolone-Modifying Enzymes among Pseudomonas aeruginosa Clinical Isolates in Europe

José Manuel Ortiz de la Rosa et al. Antimicrob Agents Chemother. .

Abstract

Many transferable quinolone resistance mechanisms have been identified in Gram-negative bacteria. The plasmid-encoded 65-amino-acid-long ciprofloxacin-modifying enzyme CrpP was recently identified in Pseudomonas aeruginosa isolates. We analyzed a collection of 100 clonally unrelated and multidrug-resistant P. aeruginosa clinical isolates, among which 46 were positive for crpP-like genes, encoding five CrpP variants conferring variable levels of reduced susceptibility to fluoroquinolones. These crpP-like genes were chromosomally located as part of pathogenicity genomic islands.

Keywords: CrpP; Pseudomonas aeruginosa; ciprofloxacin; fluoroquinolones.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Sequence comparison between pUM505 and PAGIs (60, 196, and 598). Arrows and arrowheads indicate open reading frames and their direction of transcription. Shading between bars indicates portions of sequences that align with each other. The map was drawn using Kablammo software (http://kablammo.wasmuthlab.org/).

References

    1. Hooper DC, Jacoby GA. 2016. Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med 6:a025320. doi:10.1101/cshperspect.a025320. - DOI - PMC - PubMed
    1. Martinez-Martinez L, Pascual A, Jacoby GA. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797–799. doi:10.1016/S0140-6736(97)07322-4. - DOI - PubMed
    1. Ruiz J, Pons MJ, Gomes C. 2012. Transferable mechanisms of quinolone resistance. Int J Antimicrob Agents 40:196–203. doi:10.1016/j.ijantimicag.2012.02.011. - DOI - PubMed
    1. Rehman A, Patrick WM, Lamont IL. 2019. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol 68:1–10. doi:10.1099/jmm.0.000873. - DOI - PubMed
    1. El-Badawy MF, Alrobaian MM, Shohayeb MM, Abdelwahab SF. 2019. Investigation of six plasmid-mediated quinolone resistance genes among clinical isolates of pseudomonas: a genotypic study in Saudi Arabia. Infect Drug Resist 12:915–923. doi:10.2147/IDR.S203288. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources